Association of Vascular Endothelial Growth Factor (VEGF) in Salivary Gland Tumors

Aim: To identify the association of vascular endothelial growth factor (VEGF) immunoexpression in progression salivary gland tumor. Study design: Comparative cross-sectional study Place and duration study: Department Pathology, Peshawar Medical College. Duration was six months from date approval. Methodology: Forty five specimen tumor were studied which 30 benign 15 malignant. The endpoint assessment included Hematoxylin & Eosin (H&E) VEGF immunoexpression. Results: expression with statistical significant (P<0.05). Maximum 18 samples (benign: 13, malignant: 5) shown to have strong expression, 24 16, 8) moderate expression. Whereas, small no found 2 0, 2) 1 1, 0) sample, respectively. Conclusion: Overexpression both malignant tumors might be associated progress tumors. Keywords Benign tumor, Warthin Adenoma, Salivary carcinoma, Vascular